BP Invests in Hull Wood Acetylation Venture


UK energy giant BP will invest more than $25 million over two years in a consortium that will build and operate a wood elements acetylation plant in Hull, UK.
The new company, Tricoya Ventures UK (TVUK), has been formed in partnership with Tricoya Technologies, a subsidiary of Accsys Technology, and Medite, a producer of medium-density fiberboard (MDF). Equity stakes were not disclosed.
BP said the facility at the Saltend Chemicals Park will be the world’s first Tricoya wood elements acetylation plant, and output will be targeted for the European market. Initial capacity is expected to be 30,000 t/y. The wood chips will be treated with acetic anhydride produced by BP Chemicals at Saltend and then used to produce high-performance MDF or particle board panels.
“The co-location of the Tricoya Ventures UK pant with our acetic acid facility creates natural synergies and the foundation for a great partnership,” said Nigel Dunn, vice president of global acetyls at BP.
Paul Clegg, CEO of Accsys and chairman of Tricoya Technologies, said the new manufacturing capacity will allow it to take advantage of the substantial growing market opportunity for Tricoya, which is seeing continuous growth in demand.
most read

PMMA as an Ideal Material for the Circular Economy
The versatile material polymethyl methacrylate (PMMA) is particularly impressive due to its durability and outstanding recyclability.

What’s Next for Pharma Supply Chains?
Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.

DE&I Cuts: What’s at Stake for the Chemical Industry?
Diversity, equity, and inclusion (DE&I) initiatives have become increasingly important for attracting diverse perspectives, improving problem solving and advancing innovation in companies.

Asahi Kasei to Exit MMA and PMMA Businesses
Asahi Kasei will end the production of methyl methacrylate (MMA) monomer and other chemicals and focus on its Energy & Infrastructure division.

Merck & Co. Breaks Ground on $1 Billion Biologics Center in US
Merck Wilmington Biotech will serve as a launch and commercial production facility and the future US home for Keytruda.